Oral 11ß-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial. (2022)
Attributed to:
MICA: Treatment According to Response in Giant cEll arTeritis (TARGET)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1530/eje-21-1197
PubMed Identifier: 35113805
Publication URI: http://europepmc.org/abstract/MED/35113805
Type: Journal Article/Review
Volume: 186
Parent Publication: European journal of endocrinology
Issue: 4
ISSN: 0804-4643